Monaco Asset Management SAM Buys 1,201,947 Shares of Teladoc Health, Inc. $TDOC

Monaco Asset Management SAM grew its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 159.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,956,947 shares of the health services provider’s stock after purchasing an additional 1,201,947 shares during the quarter. Teladoc Health makes up about 2.4% of Monaco Asset Management SAM’s holdings, making the stock its 8th biggest position. Monaco Asset Management SAM’s holdings in Teladoc Health were worth $13,699,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. raised its holdings in Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after purchasing an additional 2,810 shares in the last quarter. IFP Advisors Inc raised its holdings in Teladoc Health by 412.1% during the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares in the last quarter. Aster Capital Management DIFC Ltd raised its holdings in Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,425 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in Teladoc Health during the fourth quarter worth approximately $45,000. Finally, KBC Group NV increased its holdings in shares of Teladoc Health by 88.3% in the 4th quarter. KBC Group NV now owns 9,632 shares of the health services provider’s stock valued at $67,000 after acquiring an additional 4,516 shares during the period. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health News Roundup

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Teladoc announced that its virtual care services are now available through Walmart’s Better Care Services platform, giving the company access to Walmart’s large customer base and potentially expanding adoption of services like virtual urgent care, dermatology, and nutrition. Article Title
• Positive Sentiment: Investors also reacted favorably to coverage noting that the Walmart deal broadens Teladoc’s distribution, with BofA describing the move as a modest positive for the stock. Article Title
• Positive Sentiment: Shares have also been supported by momentum after the latest earnings report, with the stock up sharply since results were released and analysts watching whether the post-earnings strength can continue. Article Title
• Neutral Sentiment: Recent roundup coverage on Q1 results did not add a major new catalyst, but it kept attention on how Teladoc is performing relative to peers in the online marketplace and healthcare services space. Article Title
• Neutral Sentiment: Jefferies raised its price target on Teladoc, but kept a Hold rating, signaling some improved outlook without a full bullish conviction. Article Title

Insiders Place Their Bets

In related news, CEO Charles Divita III sold 27,731 shares of Teladoc Health stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the transaction, the chief executive officer directly owned 364,784 shares in the company, valued at $2,002,664.16. This trade represents a 7.06% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.70% of the stock is currently owned by company insiders.

Teladoc Health Stock Performance

NYSE:TDOC opened at $7.62 on Monday. The firm’s fifty day moving average price is $6.01 and its 200 day moving average price is $6.21. Teladoc Health, Inc. has a 1-year low of $4.40 and a 1-year high of $9.77. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of -7.85 and a beta of 2.14.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The firm had revenue of $613.85 million during the quarter, compared to analysts’ expectations of $611.04 million. During the same quarter last year, the business earned ($0.53) earnings per share. The business’s quarterly revenue was down 2.5% on a year-over-year basis. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, sell-side analysts expect that Teladoc Health, Inc. will post -0.91 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on TDOC shares. TD Cowen cut their target price on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a report on Thursday, February 26th. JPMorgan Chase & Co. cut their target price on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating on the stock in a report on Friday, March 13th. Oppenheimer cut their target price on shares of Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday, March 3rd. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft raised shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a report on Tuesday, March 10th. Five equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $7.43.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.